↓ Skip to main content

Thiamine for Alzheimer's disease

Overview of attention for article published in Cochrane database of systematic reviews, April 2001
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thiamine for Alzheimer's disease
Published in
Cochrane database of systematic reviews, April 2001
DOI 10.1002/14651858.cd001498
Pubmed ID
Authors

José-Luis Rodríguez, Nawab Qizilbash, Jess López-Arrieta

Abstract

Vitamin B1 (thiamine) plays an important role in Wernicke-Korsakoff syndrome (a form of amnesia caused by brain damage occurring in long-term alcoholics who rely mainly on alcohol for nutrition). The acute syndrome is normally reversible but may proceed to profound dementia, although its progress can be stopped by a timely injection of a large dose of thiamine. There have been suggestions that thiamine may have a beneficial effect in Alzheimer's disease.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Portugal 1 2%
United States 1 2%
Unknown 57 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 20%
Researcher 10 17%
Student > Bachelor 7 12%
Unspecified 7 12%
Other 5 8%
Other 19 32%
Readers by discipline Count As %
Medicine and Dentistry 15 25%
Unspecified 14 23%
Psychology 10 17%
Neuroscience 5 8%
Nursing and Health Professions 5 8%
Other 11 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2017.
All research outputs
#10,023,979
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,102
of 8,923 outputs
Outputs of similar age
#184,762
of 272,906 outputs
Outputs of similar age from Cochrane database of systematic reviews
#216
of 232 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,906 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 232 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.